About this episode
In this episode of The Swine Health Blackbelt Podcast, Dr. Nicholas Lauterbach from Pharmgate Animal Health explains the impact of PRRSV and why it remains one of the most costly diseases for pork producers. The discussion focuses on the efficacy of a modified live immunization strategy during a 1-4-4 L1C PRRSV challenge, using a study designed to reflect real-world production conditions. Results highlight differences in viral circulation, growth performance, and mortality under lateral challenge pressure. Listen now on all major platforms!"The lineage 1-4-4 L1C is one of, if not the most commonly found PRRSV strain today, while also causing some of the most drastic clinical signs."๐ ๐ฒ๐ฒ๐ ๐๐ต๐ฒ ๐ด๐๐ฒ๐๐: Dr. Nicholas Lauterbach earned his Doctor of Veterinary Medicine from Iowa State University and has worked extensively in commercial swine systems across the Midwest. He previously served as a senior veterinarian for Smithfield Foods and currently leads technical services at Pharmgate Animal Health. His work focuses on applied swine health research, PRRSV management strategies, and field-relevant immunization strategies.ย Liked this one? Donโt stop now โ Hereโs what we think youโll love!What you will learn:(00:00) Highlight(01:18) Introduction(01:43) Guest background(02:29) PRRSV challenge(05:41) Trial design(08:05) Results insights(10:03) Immunization outcomes(14:55) Closing thoughtsThe Swine Health Blackbelt Podcast is trusted and supported by innovative companies like:Pharmgate*ย Boehringer Ingelheim- Elanco๐๐ถ๐๐๐ฒ๐ป ๐ผ๐ป ๐๐ฝ๐ฝ๐น๐ฒ ๐ฃ๐ผ๐ฑ๐ฐ๐ฎ๐๐๐, ๐ฆ๐ฝ๐ผ๐๐ถ๐ณ๐ ๐ผ๐ฟ ๐ฎ๐ป๐ ๐บ๐ฎ๐ท๐ผ๐ฟ ๐ฝ๐น๐ฎ๐๐ณ๐ผ๐ฟ๐บ.Website:ย The Swine Health Blackbelt PodcastInstagram:ย Swine CampusLinkedIn:ย Swine Campus
